No Prescription |
 |
 | ||
|
Malirid Generic Primaquine |
|
| ||
No Prescription » Prescription Drugs 10 » Malirid Generic Primaquine prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This drug may also be used to treat another kind of malaria Plasmodium ovale. It may also be used with other medications to treat Pneumocystis pneumonia in AIDS patients.How to use Primaquine OralTake this medication by mouth with or without food usually once daily for 14 days. Follow your doctor's directions exactly. If stomach upset occurs take primaquine with food.Dosage is based on the kind of infection you have and response to treatment.This medication works best when the amount of drug in your body is kept at a constant level. Therefore take this drug and other antiparasitic drugs at evenly spaced intervals exactly as prescribed by your doctor. To help you remember take it at the same time each day.Do not take more or less of this drug than prescribed. Do not stop taking it before completing this prescription unless directed to do so by your doctor even if you feel better. Skipping or changing your dose without approval from your doctor may cause the amount of parasite to increase make the infection more difficult to treat (resistant) or worsen side effects.Tell your doctor if your condition persists or worsens after 1-2 days of taking this medication. If your fever returns after you have completed your treatment with this prescription contact your doctor so that he/she can determine if the malaria has returned.Primaquine Oral is used to treat the following:Malaria caused by the Protozoa Plasmodium Vivax Preventive Treatment of Vivax Malaria Malaria caused by the Protozoa Plasmodium Ovale Preventive Treatment of Ovale MalariaPrimaquine Oral may also be used to treat:Malaria caused by the Protozoa Plasmodium Falciparum Prevention of Falciparum Malaria Prevention of Falciparum Malaria that is Resistant to Chloroquine Pneumonia caused by Pneumocystis Carinii Buy Malirid Generic Primaquine and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About Malirid Generic Primaquine: Product Type: Prescription Drugs 10 Malirid ( Generic Primaquine ) Malirid (Generic Primaquine) Generic Primaquine 15mg 140 Tablets-DT 15mg 2 x 140 Tablets-DT 7.5mg 100 Tablets 7.5mg 200(2 x 100 Tablets) 7.5mg 400(4 x 100 Tablets) Generic Primaquine Malirid
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
